fda compounding glp-1 warning letters september 2025 15, 2025: Telehealth company must stop implying its compounded GLP -1 is FDA-approved, warns – Partnership for Safe Medicines FDA issued 25 warning letters

Here's what FDA approvals, ADA guidelines and recent trials actually say.

This patch helps suppress appetite, supporting portion control and reducing the temptation to overeat

In this follow-up, were going to look specifically at tirzepatide, one of the more recent and most popular GLP-1 agonists

The results showed that BA1b significantly reduced blood glucose and serum insulin levels, promoted secretion of glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1) in diabetic mice

Lifevantage (NASDAQ:LFVN) executives outlined the companys business model, product portfolio, financial profile, and growth priorities during a recent investor presentation and Q&A, highlighting a subscription-heavy revenue base, expanding product categories, and a balanced approach to capital

Research to better understand and ultimately mitigate this heightened susceptibility is an important priority for new drug development in this area, and novel approaches to model the impact of endogenous hormone signaling will be critical to developing better treatments for more people